These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
181 related items for PubMed ID: 22152378
41. MCD-induced steatohepatitis is associated with hepatic adiponectin resistance and adipogenic transformation of hepatocytes. Larter CZ, Yeh MM, Williams J, Bell-Anderson KS, Farrell GC. J Hepatol; 2008 Sep; 49(3):407-16. PubMed ID: 18534710 [Abstract] [Full Text] [Related]
42. Alpha-lipoic acid attenuates methionine choline deficient diet-induced steatohepatitis in C57BL/6 mice. Min AK, Kim MK, Kim HS, Seo HY, Lee KU, Kim JG, Park KG, Lee IK. Life Sci; 2012 Jan 30; 90(5-6):200-5. PubMed ID: 22154902 [Abstract] [Full Text] [Related]
43. Effects of treatment with hydrogen sulfide on methionine-choline deficient diet-induced non-alcoholic steatohepatitis in rats. Luo ZL, Tang LJ, Wang T, Dai RW, Ren JD, Cheng L, Xiang K, Tian FZ. J Gastroenterol Hepatol; 2014 Jan 30; 29(1):215-22. PubMed ID: 24117897 [Abstract] [Full Text] [Related]
44. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice. Malloy VL, Perrone CE, Mattocks DA, Ables GP, Caliendo NS, Orentreich DS, Orentreich N. Metabolism; 2013 Nov 30; 62(11):1651-61. PubMed ID: 23928105 [Abstract] [Full Text] [Related]
45. Activation of peroxisome proliferator-activated receptor alpha by dietary fish oil attenuates steatosis, but does not prevent experimental steatohepatitis because of hepatic lipoperoxide accumulation. Larter CZ, Yeh MM, Cheng J, Williams J, Brown S, dela Pena A, Bell-Anderson KS, Farrell GC. J Gastroenterol Hepatol; 2008 Feb 30; 23(2):267-75. PubMed ID: 17868330 [Abstract] [Full Text] [Related]
46. Sesame oil mitigates nutritional steatohepatitis via attenuation of oxidative stress and inflammation: a tale of two-hit hypothesis. Periasamy S, Chien SP, Chang PC, Hsu DZ, Liu MY. J Nutr Biochem; 2014 Feb 30; 25(2):232-40. PubMed ID: 24445049 [Abstract] [Full Text] [Related]
47. CXC chemokine receptor 3 promotes steatohepatitis in mice through mediating inflammatory cytokines, macrophages and autophagy. Zhang X, Han J, Man K, Li X, Du J, Chu ES, Go MY, Sung JJ, Yu J. J Hepatol; 2016 Jan 30; 64(1):160-70. PubMed ID: 26394162 [Abstract] [Full Text] [Related]
48. Mitochondrial gene polymorphisms alter hepatic cellular energy metabolism and aggravate diet-induced non-alcoholic steatohepatitis. Schröder T, Kucharczyk D, Bär F, Pagel R, Derer S, Jendrek ST, Sünderhauf A, Brethack AK, Hirose M, Möller S, Künstner A, Bischof J, Weyers I, Heeren J, Koczan D, Schmid SM, Divanovic S, Giles DA, Adamski J, Fellermann K, Lehnert H, Köhl J, Ibrahim S, Sina C. Mol Metab; 2016 Apr 30; 5(4):283-295. PubMed ID: 27069868 [Abstract] [Full Text] [Related]
49. Polaprezinc attenuates liver fibrosis in a mouse model of non-alcoholic steatohepatitis. Sugino H, Kumagai N, Watanabe S, Toda K, Takeuchi O, Tsunematsu S, Morinaga S, Tsuchimoto K. J Gastroenterol Hepatol; 2008 Dec 30; 23(12):1909-16. PubMed ID: 18422963 [Abstract] [Full Text] [Related]
50. Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a dietary murine model. Sahai A, Malladi P, Melin-Aldana H, Green RM, Whitington PF. Am J Physiol Gastrointest Liver Physiol; 2004 Jul 30; 287(1):G264-73. PubMed ID: 15044174 [Abstract] [Full Text] [Related]
51. [Activation of Fas/FasL and its downstream signaling pathway promotes development of alcoholic steatohepatitis and liver fibrosis in mice]. Ren WG, Kong LB, Mi HM, Zhao SX, Zhang YG, Wang RQ, Nan YM. Zhonghua Gan Zang Bing Za Zhi; 2013 Feb 30; 21(2):129-33. PubMed ID: 23663886 [Abstract] [Full Text] [Related]
55. Effect of Trifolium pratense extract on methionine-choline-deficient diet-induced steatohepatitis in C57BL/6 mice. Chen T, Zhong FJ, Hong YM, Su WJ, Zhuang LL, Qiu LX. Chin J Nat Med; 2014 Mar 30; 12(3):194-8. PubMed ID: 24702805 [Abstract] [Full Text] [Related]
56. Farnesoid X receptor agonist WAY-362450 attenuates liver inflammation and fibrosis in murine model of non-alcoholic steatohepatitis. Zhang S, Wang J, Liu Q, Harnish DC. J Hepatol; 2009 Aug 30; 51(2):380-8. PubMed ID: 19501927 [Abstract] [Full Text] [Related]
58. Role of ADAMTS13 in diet-induced liver steatosis. Geys L, Roose E, Vanhoorelbeke K, Bedossa P, Scroyen I, Lijnen HR. Mol Med Rep; 2017 Aug 30; 16(2):1451-1458. PubMed ID: 29067443 [Abstract] [Full Text] [Related]
59. Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis. Witek RP, Stone WC, Karaca FG, Syn WK, Pereira TA, Agboola KM, Omenetti A, Jung Y, Teaberry V, Choi SS, Guy CD, Pollard J, Charlton P, Diehl AM. Hepatology; 2009 Nov 30; 50(5):1421-30. PubMed ID: 19676126 [Abstract] [Full Text] [Related]
60. Anti-apoptotic and anti-inflammatory effects of Silybum marianum in treatment of experimental steatohepatitis. Aghazadeh S, Amini R, Yazdanparast R, Ghaffari SH. Exp Toxicol Pathol; 2011 Sep 30; 63(6):569-74. PubMed ID: 20471811 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]